NCAN and metabolic dysfunction-associated steatotic liver disease: In addition to plasma lipid levels, the NCAN-CILP2 region was identified as a non-alcoholic fatty liver disease (NALFD)–associated locus by GWAS in individuals of European descent [9] but not in Japanese individuals [10, 11].